Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00653432 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee
A NA study, sponsored by Anika Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 369
- Enrollment target
NCT00653432 is a NA study that has completed, run by Anika Therapeutics. The registered enrollment target is 369 participants.
The verdict
NCT00653432, a NA study, has completed, sponsored by Anika Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 369 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether intra-articular injection of Monovisc® hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.
Interventions
- OTHER Saline
- DEVICE Monovisc®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00653432
The ClinicalTrials.gov registry entry for NCT00653432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anika Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00653432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00653432 about?
NCT00653432 is a clinical study titled "Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee". The purpose of this study is to determine whether intra-articular injection of Monovisc® hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.
What is the current status of trial NCT00653432?
This trial is currently completed. It is a NA study. The enrollment target is 369 participants. The study started on 2008-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00653432?
The interventions under investigation include: Saline (OTHER), Monovisc® (DEVICE).
Who is sponsoring clinical trial NCT00653432?
This trial is sponsored by Anika Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.